Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing
- PMID: 1588289
- PMCID: PMC2119267
- DOI: 10.1084/jem.175.6.1717
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing
Abstract
Recombinant granulocyte/macrophage-colony-stimulating factor (rGM-CSF), prepared from Chinese hamster ovary (CHO) cells and Escherichia coli, was administered to 35 patients with the borderline and polar lepromatous forms of leprosy by the intradermal and subcutaneous routes at doses of 7.5-45.0 micrograms/d for 10 d. With each of these doses and routes, increases in the number of circulating eosinophils were noted. After the intradermal injection, the local skin sites demonstrated zones of roughening and micronodularity that appeared within 24-48 h and persisted for more than 6 d. Reinjection of sites led to enhanced areas of epidermal reaction. GM-CSF prepared from CHO cells was a more potent inducer of this effect. GM-CSF given by the subcutaneous route, at higher doses, failed to initiate these changes. At the microscopic level, the epidermis became thickened (+75%) with increased numbers and layers of enlarged keratinocytes. These contained increased numbers of ribosomes and prominent nucleoli, and were imbedded in a looser meshwork of the zona Pellucida. The modified keratinocytes remained MHC class II antigen negative throughout the course of the response. A major change in the dermis was the progressive accumulation of CD1+, Birbeck granule-positive cells. These Langerhans were recognizable at 48 h after intradermal injection and reached maximum numbers by 4 d. During this period the number of epidermal Langerhans cells remained relatively constant. No increment in dermal Langerhans cells occurred when GLM-CSF was injected by the subcutaneous route. No appreciable increase in the numbers of T cells and monocytes was noted, and granulocytes and eosinophils were largely present within the dermal microvasculature. 4-mm punch biopsies taken from injected sites and adjacent controls were compared in terms of the rapidity of wound healing. 22 of 26 sites demonstrated more rapid filling and hemostasis, whereas four were equivalent to controls. We conclude that rGM-CSF, when introduced into the skin, leads to enhanced keratinocyte growth, the selective recruitment of Langerhans cells into the dermis, and enhanced wound healing of the prepared site. There was no evidence of an enhanced cell-mediated response to Mycobacterium leprae, and bacillary numbers remained unchanged.
Similar articles
-
Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.Br J Dermatol. 1998 Aug;139(2):239-46. doi: 10.1046/j.1365-2133.1998.02360.x. Br J Dermatol. 1998. PMID: 9767237
-
GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo.J Invest Dermatol. 1994 Oct;103(4):601-4. doi: 10.1111/1523-1747.ep12396936. J Invest Dermatol. 1994. PMID: 7930689
-
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.Am J Pathol. 1987 Aug;128(2):345-53. Am J Pathol. 1987. PMID: 3113256 Free PMC article.
-
Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.Surg Technol Int. 2018 Jun 1;32:61-66. Surg Technol Int. 2018. PMID: 29611156 Review.
-
Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits.Int Rev Exp Pathol. 1993;34 Pt B:43-67. doi: 10.1016/b978-0-12-364935-5.50009-2. Int Rev Exp Pathol. 1993. PMID: 8458717 Review.
Cited by
-
Granulocyte/macrophage colony-stimulating factor influences angiogenesis by regulating the coordinated expression of VEGF and the Ang/Tie system.PLoS One. 2014 Mar 21;9(3):e92691. doi: 10.1371/journal.pone.0092691. eCollection 2014. PLoS One. 2014. PMID: 24658178 Free PMC article.
-
Innate Immune Responses in Leprosy.Front Immunol. 2018 Mar 28;9:518. doi: 10.3389/fimmu.2018.00518. eCollection 2018. Front Immunol. 2018. PMID: 29643852 Free PMC article. Review.
-
Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.Virchows Arch. 1994;424(6):601-6. doi: 10.1007/BF00195773. Virchows Arch. 1994. PMID: 8055153
-
Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.Thorax. 1996 Jun;51(6):611-4. doi: 10.1136/thx.51.6.611. Thorax. 1996. PMID: 8693443 Free PMC article.
-
The continuing challenges of leprosy.Clin Microbiol Rev. 2006 Apr;19(2):338-81. doi: 10.1128/CMR.19.2.338-381.2006. Clin Microbiol Rev. 2006. PMID: 16614253 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials